Last reviewed · How we verify
Airsupra
At a glance
| Generic name | Airsupra |
|---|---|
| Sponsor | Massachusetts General Hospital |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- GRANITE: Airsupra Effectiveness in the Real World
- Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma. (PHASE3)
- Study to Investigate Changes in Airway Inflammation, Symptoms, and Rescue Therapy Utilization With AIRSUPRA Compared to Albuterol as Needed in Adults With Mild Asthma (PHASE4)
- Individualizing Treatment for Asthma in Primary Care (Full Study) (PHASE4)
- 45th Multicenter Airway Research Collaboration (PHASE4)
- Individualizing Treatment for Asthma in Primary Care (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Airsupra CI brief — competitive landscape report
- Airsupra updates RSS · CI watch RSS
- Massachusetts General Hospital portfolio CI